×
0 0 0 0 0 0 0 0
Stockreport

TG Therapeutics: Further Appreciation In 2018 Likely [Seeking Alpha]

TG THERAPEUTICS (TGTX)  More Company Research Source: Seeking Alpha
Last tg therapeutics earnings: 8/7 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.tgtherapeutics.com
PDF TG Therapeutics: Further Appreciation In 2018 LikelySummaryShares have started the year with a powerful run up.Ublituximab continues to look quite promising in RMS.The in-licensing of Jiangsu Hengrui Medicine Co.'s BTK inhibitor program was a masterful move that could pay dividends down the road for shareholders.Several key catalysts are coming up over the next few quarters.Readers who have done their due diligence should purchase a pilot position in the near term, taking advantage of any resulting weakness (i.e. from a possible secondary) to add shares. [Read more]

IMPACT SNAPSHOT EVENT TIME: TGTX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
TGTX alerts

from News Quantified
Opt-in for
TGTX alerts

from News Quantified